COPD Trial, Recruiting NCT03807310 Sponsor: Maastricht University Medical Center Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT03807310
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

For COPD Patients:

Who might be able to join this trial:

  • You have been diagnosed with moderate to very severe COPD (known as GOLD stage II, III, or IV)
  • Your condition is currently stable and not in a period of sudden worsening

Who may not be able to join:

  • You are under 18 years old
  • You have an allergy or intolerance to any ingredients in the study product
  • You are unwilling or unable to stop taking vitamin D or fatty acid (fish oil/omega-3 type) supplements during the study
  • The study doctor has concerns about your ability to follow the study requirements, or you have another serious or unstable illness (such as active cancer being treated)
  • You are currently in another clinical study, or have been in one within the last four weeks
  • You have a terminal illness
  • You have been admitted to hospital in the last four weeks
  • You have recently (within the last four weeks) used oral steroids or antibiotics due to a COPD flare-up
  • You have had lung cancer within the last five years
  • You have a diagnosis of dementia or a brain-related degenerative condition (such as Alzheimer's, Parkinson's, or similar diseases)
  • You have been diagnosed within the last year with a brain or stroke-related condition (such as a stroke, brain bleed, brain tumour, or mini-stroke)
  • You have a medical condition that seriously affects your digestion or gut function (confirm with trial site)

For Healthy Volunteers:

Who might be able to join this trial:

  • Your lung function test results show a healthy breathing capacity (confirm with trial site for specific measurements)
  • You are currently in good, stable health

Who may not be able to join:

  • You are under 18 years old
  • The study doctor has concerns about your ability to follow the study requirements, or you have a serious or unstable illness (such as active cancer being treated)
  • You are currently in another clinical study, or have been in one within the last four weeks
  • You have a terminal illness
  • You have been admitted to hospital in the last four weeks
  • You have taken antibiotics in the last four weeks
  • You have had lung cancer within the last five years
  • You have a diagnosis of dementia or a brain-related degenerative condition (such as Alzheimer's, Parkinson's, or similar diseases)
  • You have been diagnosed within the last year with a brain or stroke-related condition (such as a stroke, brain bleed, brain tumour, or mini-stroke)
  • You have a medical condition that seriously affects your digestion or gut function (confirm with trial site)
  • You have been diagnosed with any chronic lung disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Annemie Schols, Prof. dr., Maastricht UMC+ / NUTRIM, Department of Respiratory Medicine

Phone: +31433882990

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 February 2020
Est. completion
1 July 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Change in physical activity level assessed by measuring step count with accelerometry; Change in generic health status measured by EuroQol-5 dimensions (EQ-5D)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov